Attached files
file | filename |
---|---|
S-1/A - S-1/A - Sio Gene Therapies Inc. | a2224888zs-1a.htm |
EX-5.1 - EX-5.1 - Sio Gene Therapies Inc. | a2224888zex-5_1.htm |
EX-3.4 - EX-3.4 - Sio Gene Therapies Inc. | a2224888zex-3_4.htm |
EX-1.1 - EX-1.1 - Sio Gene Therapies Inc. | a2224888zex-1_1.htm |
EX-10.9 - EX-10.9 - Sio Gene Therapies Inc. | a2224888zex-10_9.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1/A of Axovant Sciences Ltd. of our report dated May 21, 2015 relating to the financial statements of Axovant Sciences Ltd., which appears in such Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP |
|
Florham Park, New Jersey |
|
May 29, 2015 |
|